Humanigen Inc (HGENQ)

[cowtown jay]

"New long COVID study uncovers high inflammation in patients as Senate calls for more research on 'crisis'"
ASHLEY RIEGLE
Wed, January 24, 2024

https://www.yahoo.com/gma/long-covid-study-uncovers-high-011010645.html

If Long Covid has now advanced to the crisis stage, and since it is caused by high inflammation, how much longer can lenz be ignored as the premier treatment therapeutic for this indication? Or, HAS lenz been ignored? I recall that lenz was submitted as a treatment candidate for this indication. Is Long Covid going to be a new indication for lenz, causing regulatory approval and further stimulating investor demand ahead of the company's recall of their loaned shares? Is this why Durrant is both the stalking horse bidder, as well as the DIP lender?